外科理论与实践 ›› 2022, Vol. 27 ›› Issue (01): 87-90.doi: 10.16139/j.1007-9610.2022.01.020

• 综述 • 上一篇    下一篇

胆囊腺肌症的发病机制及诊治研究进展

陈炫武1, 杨传玉1, 蒋敏杰 综述1, 杜卫东 审校2()   

  1. 1.浙江中医药大学第一临床医学院,浙江 杭州 310053
    2.浙江中医药大学附属第一医院肝胆外科,浙江 杭州 310053
  • 收稿日期:2021-04-01 出版日期:2022-01-25 发布日期:2022-03-17
  • 通讯作者: 杜卫东 E-mail:doctordu@sina.cn

Progress of study on gallbladder adenomyomatosis: pathogenesis, diagnosis and treatment

CHEN Xuanwu1, YANG Chuanyu1, JIANG Minjie1, DU Weidong2()   

  1. 1. The First Clinical Medical College of Zhejiang Chinese Medical University, Zhejiang Hangzhou 310053, China
    2. Department of Hepatological Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Hangzhou 310053, China
  • Received:2021-04-01 Online:2022-01-25 Published:2022-03-17

摘要:

胆囊腺肌症(gallbladder adenomyomatosis,GA)是一种临床上较少见、病因及发病机制不明的良性疾病。随着影像检测技术的发展,其诊断有进一步提高。部分学者认为GA与胆囊癌的形成有关,但尚存争议。GA的治疗,有主张胆囊切除,以预防其恶变,也有学者认为部分GA可行随访。目前尚无共识。本文对GA的病因、发病机制和诊治进展进行综述。

关键词: 胆囊腺肌症, 罗-阿窦, 胆囊癌

Abstract:

Gallbladder adenomyomatosis(GA) is a relatively rare benign disease of unknown both etiology and pathogenesis. The development of imaging technology improved diagnosis of GA. Some believed that GA related to gallbladder cancer, which is still controversial. Preventive cholecystectomy was proposed to treat GA and some GA could be followed up. Therefore no consensus of treatment of GA is present now. Etiology, pathogenesis, diagnosis and treatment of GA were included in this article.

Key words: Gallbladder adenomyomatosis, Rokitansky-Ashoff sinus, Gallbladder carcinoma

中图分类号: